Xiaobin Wu sold $27M of ONC
President and COO at BeOne Medicines Ltd.. 89,794 shares at an average of $304.56, traded Aug 13, 2025, filed Aug 15, 2025.
Score components
- +20RolePresident
- +25Trade size$27.3M at market
- +20Share of holdings soldSold 100% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-25-040540, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 13, 2025 | MOption exercise American Depositary Shares10b5-1 | +22,773 | $174.43 | $4.0M | 22,773 | Aug 15, 2025 |
| Aug 13, 2025 | MOption exercise American Depositary Shares10b5-1 | +27,085 | $155.68 | $4.2M | 49,858 | Aug 15, 2025 |
| Aug 13, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -8,900 | $300.33 | $2.7M | 40,958 | Aug 15, 2025 |
| Aug 13, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -4,500 | $301.49 | $1.4M | 36,458 | Aug 15, 2025 |
| Aug 13, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -5,800 | $302.45 | $1.8M | 30,658 | Aug 15, 2025 |
| Aug 13, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -3,517 | $303.54 | $1.1M | 27,141 | Aug 15, 2025 |
| Aug 13, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -7,359 | $304.37 | $2.2M | 19,782 | Aug 15, 2025 |
| Aug 13, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -528 | $305.59 | $161k | 19,254 | Aug 15, 2025 |
| Aug 13, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -9,637 | $306.74 | $3.0M | 9,617 | Aug 15, 2025 |
| Aug 13, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -9,617 | $307.38 | $3.0M | 0 | Aug 15, 2025 |
| Aug 14, 2025 | MOption exercise American Depositary Shares10b5-1 | +30,756 | $155.68 | $4.8M | 30,756 | Aug 15, 2025 |
| Aug 14, 2025 | MOption exercise American Depositary Shares10b5-1 | +9,180 | $159.03 | $1.5M | 39,936 | Aug 15, 2025 |
| Aug 14, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -400 | $300.86 | $120k | 39,536 | Aug 15, 2025 |
| Aug 14, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -5,800 | $302.04 | $1.8M | 33,736 | Aug 15, 2025 |
| Aug 14, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -6,965 | $303.31 | $2.1M | 26,771 | Aug 15, 2025 |
| Aug 14, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -500 | $304.19 | $152k | 26,271 | Aug 15, 2025 |
| Aug 14, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -8,522 | $305.48 | $2.6M | 17,749 | Aug 15, 2025 |
| Aug 14, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -12,232 | $306.26 | $3.7M | 5,517 | Aug 15, 2025 |
| Aug 14, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -4,917 | $307.43 | $1.5M | 600 | Aug 15, 2025 |
| Aug 14, 2025 | SOpen-market sale American Depositary Shares10b5-1 | -600 | $308.03 | $185k | 0 | Aug 15, 2025 |
| Aug 13, 2025 | MOption exercise Share Option (Right to Buy)derivative10b5-1 | -296,049 | $0.00 | $0 | 0 | Aug 15, 2025 |
| Aug 13, 2025 | MOption exercise Share Option (Right to Buy)derivative10b5-1 | -352,105 | $0.00 | $0 | 709,709 | Aug 15, 2025 |
| Aug 14, 2025 | MOption exercise Share Option (Right to Buy)derivative10b5-1 | -399,828 | $0.00 | $0 | 309,881 | Aug 15, 2025 |
| Aug 14, 2025 | MOption exercise Share Option (Right to Buy)derivative10b5-1 | -119,340 | $0.00 | $0 | 358,046 | Aug 15, 2025 |
Related signals
Other insiders at BeOne Medicines Ltd. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 39Weak | BeOne Medicines Ltd. | Chan Henry Lee SVP, General Counsel | $418k 1,115 shares | -100% | |
| 33Weak | BeOne Medicines Ltd. | Xiaodong Wang director, other | $11M 31,028 shares | -100% | |
| 33Weak | BeOne Medicines Ltd. | Xiaodong Wang director, other | $13M 38,287 shares | -527% | |
| 49Moderate | BeOne Medicines Ltd. | Titus B. Ball Principal Accounting Officer | $47k 132 shares | -100% | |
| 58Moderate | BeOne Medicines Ltd. | John Oyler Chief Executive Officer | $31M 100,000 shares | -100% | |
| 27Weak | BeOne Medicines Ltd. | Chan Henry Lee SVP, General Counsel | $214k 664 shares | -200% | |
| 69Notable | BeOne Medicines Ltd. | Corazon (Corsee) D. Sanders director | $896k 2,627 shares | -100% | |
| 80Strong | BeOne Medicines Ltd. | Xiaobin Wu President and COO | $1.5M 3,991 shares | -100% | |
| 80Strong | BeOne Medicines Ltd. | Xiaobin Wu President and COO | $5.8M 16,009 shares | -100% | |
| 30Weak | BeOne Medicines Ltd. | Chan Henry Lee SVP, General Counsel | $348k 996 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.